JCR Pharmaceuticals.
¥617
3
+¥5+0.82% Today
Statistics
Day High
626
Day Low
616
52W High
1,567
52W Low
522
Volume
334,100
Avg. Volume
722,415
Mkt Cap
269.79B
P/E Ratio
18.88
Dividend Yield
3.24%
Dividend
20.02
Upcoming
30
SEP
Dividend Ex
8
DEC
Dividend Payment
31
MAR 25
Dividend Ex
30
SEP 25
Dividend Ex
8
DEC 25
Dividend Payment
31
MAR 26
Dividend Ex
Dividends
3.24%Dividend Yield
10Y Growth
-1.09%
5Y Growth
-14.87%
3Y Growth
-4.97%
1Y Growth
-7.68%
Earnings
10MayConfirmed
Expected EPS
0.11026871576
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 4552.TSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
Show more...
CEO
Mr. Shin Ashida
Employees
816
Country
JP
ISIN
JP3701000006